髋关节术后异位骨化的研究进展
Research Progress of Ectopic Ossification after Hip Joint Operation
DOI: 10.12677/acm.2024.1472032, PDF,   
作者: 饶 康:延安大学医学院,陕西 延安;李长红*:延安大学附属医院创伤骨科,陕西 延安
关键词: 异位骨化髋关节术后危险因素预防治疗Ectopic Ossification Hip Joint Surgery Risk Factors Prevention Treatment
摘要: 异位骨化(Heterotopic Ossification, HO)是指在正常情况下没有骨组织的软组织内,出现了成骨细胞,并形成了骨组织。HO是髋关节骨折术后常见的并发症之一,一旦发生可能会引起较严重的后果,且由于髋关节骨折术后HO的高发病率及其发病机制的复杂性,其预防与治疗一直受到人们的关注。但学术界目前对HO发病机制的认识、最有效的预防方案、手术时机的选择、物理治疗的必要性以及基因靶向治疗的临床应用等问题尚不明确。本文通过对HO最新研究的文献进行系统评价,为髋部骨折术后HO的发病机制的研究与治疗提出专业意见。
Abstract: Heterotopic Ossification (HO) is the emergence of osteoblasts and the formation of bone tissue in soft tissues that normally do not have bone tissue. HO is one of the common complications after hip fracture, which may cause serious consequences once it occurs. Due to the high incidence and complexity of the pathogenesis of HO after hip fracture, its prevention and treatment have been concerned by people. However, the understanding of the pathogenesis of HO, the most effective preventive program, the selection of surgical timing, the necessity of physical therapy and the clinical application of gene targeted therapy are still unclear. Through a systematic review of the latest literature on HO, this paper provides professional suggestions for the study and treatment of the pathogenesis of HO after hip fracture.
文章引用:饶康, 李长红. 髋关节术后异位骨化的研究进展[J]. 临床医学进展, 2024, 14(7): 427-434. https://doi.org/10.12677/acm.2024.1472032

参考文献

[1] Cao, G., Zhang, S., Wang, Y., Quan, S., Yue, C., Yao, J., et al. (2023) Pathogenesis of Acquired Heterotopic Ossification: Risk Factors, Cellular Mechanisms, and Therapeutic Implications. Bone, 168, Article ID: 116655. [Google Scholar] [CrossRef] [PubMed]
[2] Back, D.L., Smith, J.D., Dalziel, R.E., Young, D.A. and Shimmin, A. (2007) Incidence of Heterotopic Ossification after HIP Resurfacing. ANZ Journal of Surgery, 77, 642-647. [Google Scholar] [CrossRef] [PubMed]
[3] Neal, B., Gray, H., MacMahon, S. and Dunn, L. (2002) Incidence of Heterotopic Bone Formation after Major Hip Surgery. ANZ Journal of Surgery, 72, 808-821. [Google Scholar] [CrossRef] [PubMed]
[4] Singh, S., Morshed, S., Motamedi, D., Kidane, J., Paul, A., Hsiao, E.C., et al. (2022) Identification of Risk Factors in the Development of Heterotopic Ossification after Primary Total Hip Arthroplasty. The Journal of Clinical Endocrinology & Metabolism, 107, e3944-e3952. [Google Scholar] [CrossRef] [PubMed]
[5] Zhu, Y., Zhang, F., Chen, W., Zhang, Q., Liu, S. and Zhang, Y. (2015) Incidence and Risk Factors for Heterotopic Ossification after Total Hip Arthroplasty: A Meta-Analysis. Archives of Orthopaedic and Trauma Surgery, 135, 1307-1314. [Google Scholar] [CrossRef] [PubMed]
[6] Molligan, J., Mitchell, R., Schon, L., Achilefu, S., Zahoor, T., Cho, Y., et al. (2016) Influence of Bone and Muscle Injuries on the Osteogenic Potential of Muscle Progenitors: Contribution of Tissue Environment to Heterotopic Ossification. Stem Cells Translational Medicine, 5, 745-753. [Google Scholar] [CrossRef] [PubMed]
[7] Elmstedt, E., Lindholm, T.S., Nilsson, O.S. and Törnkvist, H. (1985) Effect of Ibuprofen on Heterotopic Ossification after Hip Replacement. Acta Orthopaedica Scandinavica, 56, 25-27. [Google Scholar] [CrossRef] [PubMed]
[8] Kraft, C.T., Agarwal, S., Ranganathan, K., Wong, V.W., Loder, S., Li, J., et al. (2016) Trauma-Induced Heterotopic Bone Formation and the Role of the Immune System. Journal of Trauma and Acute Care Surgery, 80, 156-165. [Google Scholar] [CrossRef] [PubMed]
[9] Genêt, F., Kulina, I., Vaquette, C., Torossian, F., Millard, S., Pettit, A.R., et al. (2015) Neurological Heterotopic Ossification Following Spinal Cord Injury Is Triggered by Macrophage‐Mediated Inflammation in Muscle. The Journal of Pathology, 236, 229-240. [Google Scholar] [CrossRef] [PubMed]
[10] Convente, M.R., Wang, H., Pignolo, R.J., Kaplan, F.S. and Shore, E.M. (2015) The Immunological Contribution to Heterotopic Ossification Disorders. Current Osteoporosis Reports, 13, 116-124. [Google Scholar] [CrossRef] [PubMed]
[11] Convente, M.R., Chakkalakal, S.A., Yang, E., Caron, R.J., Zhang, D., Kambayashi, T., et al. (2017) Depletion of Mast Cells and Macrophages Impairs Heterotopic Ossification in an acvr1R206H Mouse Model of Fibrodysplasia Ossificans Progressiva. Journal of Bone and Mineral Research, 33, 269-282. [Google Scholar] [CrossRef] [PubMed]
[12] Kan, L., Liu, Y., McGuire, T.L., Berger, D.M.P., Awatramani, R.B., Dymecki, S.M., et al. (2009) Dysregulation of Local Stem/progenitor Cells as a Common Cellular Mechanism for Heterotopic Ossification. Stem Cells, 27, 150-156. [Google Scholar] [CrossRef] [PubMed]
[13] Ranganathan, K., Agarwal, S., Cholok, D., Loder, S., Li, J., Sung Hsieh, H.H., et al. (2016) The Role of the Adaptive Immune System in Burn-Induced Heterotopic Ossification and Mesenchymal Cell Osteogenic Differentiation. Journal of Surgical Research, 206, 53-61. [Google Scholar] [CrossRef] [PubMed]
[14] Hoff, P., Rakow, A., Gaber, T., Hahne, M., Sentürk, U., Strehl, C., et al. (2013) Preoperative Irradiation for the Prevention of Heterotopic Ossification Induces Local Inflammation in Humans. Bone, 55, 93-101. [Google Scholar] [CrossRef] [PubMed]
[15] Evans, K.N., Forsberg, J.A., Potter, B.K., Hawksworth, J.S., Brown, T.S., Andersen, R., et al. (2012) Inflammatory Cytokine and Chemokine Expression Is Associated with Heterotopic Ossification in High-Energy Penetrating War Injuries. Journal of Orthopaedic Trauma, 26, e204-e213. [Google Scholar] [CrossRef] [PubMed]
[16] Sung Hsieh, H.H., Chung, M.T., Allen, R.M., Ranganathan, K., Habbouche, J., Cholok, D., et al. (2017) Evaluation of Salivary Cytokines for Diagnosis of Both Trauma-Induced and Genetic Heterotopic Ossification. Frontiers in Endocrinology, 8, Article 74. [Google Scholar] [CrossRef] [PubMed]
[17] Forsberg, J.A., Potter, B.K., Polfer, E.M., Safford, S.D. and Elster, E.A. (2014) Do Inflammatory Markers Portend Heterotopic Ossification and Wound Failure in Combat Wounds? Clinical Orthopaedics & Related Research, 472, 2845-2854. [Google Scholar] [CrossRef] [PubMed]
[18] Urist, M.R. (1965) Bone: Formation by Autoinduction. Science, 150, 893-899. [Google Scholar] [CrossRef] [PubMed]
[19] Delaney, K., Kasprzycka, P., Ciemerych, M.A. and Zimowska, M. (2017) The Role of TGF‐β1 during Skeletal Muscle Regeneration. Cell Biology International, 41, 706-715. [Google Scholar] [CrossRef] [PubMed]
[20] Ranganathan, K., Loder, S., Agarwal, S., Wong, V.W., Forsberg, J., Davis, T.A., et al. (2015) Heterotopic Ossification: Basic-Science Principles and Clinical Correlates. Journal of Bone and Joint Surgery, 97, 1101-1111. [Google Scholar] [CrossRef] [PubMed]
[21] Leblanc, E., Trensz, F., Haroun, S., Drouin, G., Bergeron, É., Penton, C.M., et al. (2010) BMP-9-Induced Muscle Heterotopic Ossification Requires Changes to the Skeletal Muscle Microenvironment. Journal of Bone and Mineral Research, 26, 1166-1177. [Google Scholar] [CrossRef] [PubMed]
[22] Hino, K., Ikeya, M., Horigome, K., Matsumoto, Y., Ebise, H., Nishio, M., et al. (2015) Neofunction of ACVR1 in Fibrodysplasia Ossificans Progressiva. Proceedings of the National Academy of Sciences of the United States of America, 112, 15438-15443. [Google Scholar] [CrossRef] [PubMed]
[23] Phornphutkul, C., Wu, K., Auyeung, V., Chen, Q. and Gruppuso, P.A. (2008) mTOR Signaling Contributes to Chondrocyte Differentiation. Developmental Dynamics, 237, 702-712. [Google Scholar] [CrossRef] [PubMed]
[24] Laplante, M. and Sabatini, D.M. (2009) mTOR Signaling at a Glance. Journal of Cell Science, 122, 3589-3594. [Google Scholar] [CrossRef] [PubMed]
[25] Galdones, E. and Hales, B.F. (2008) Retinoic Acid Receptor Gamma-Induced Misregulation of Chondrogenesis in the Murine Limb Bud in Vitro. Toxicological Sciences, 106, 223-232. [Google Scholar] [CrossRef] [PubMed]
[26] Romand, R., Hashino, E., Dollé, P., Vonesch, J., Chambon, P. and Ghyselinck, N.B. (2002) The Retinoic Acid Receptors RARα and RARγ Are Required for Inner Ear Development. Mechanisms of Development, 119, 213-223. [Google Scholar] [CrossRef] [PubMed]
[27] Cash, D.E., Bock, C.B., Schughart, K., Linney, E. and Underhill, T.M. (1997) Retinoic Acid Receptor α Function in Vertebrate Limb Skeletogenesis: A Modulator of Chondrogenesis. The Journal of Cell Biology, 136, 445-457. [Google Scholar] [CrossRef] [PubMed]
[28] Shimono, K., Morrison, T.N., Tung, W., Chandraratna, R.A., Williams, J.A., Iwamoto, M., et al. (2009) Inhibition of Ectopic Bone Formation by a Selective Retinoic Acid Receptor α‐Agonist: A New Therapy for Heterotopic Ossification? Journal of Orthopaedic Research, 28, 271-277. [Google Scholar] [CrossRef] [PubMed]
[29] Mitchell, K.J., Pannérec, A., Cadot, B., Parlakian, A., Besson, V., Gomes, E.R., et al. (2010) Identification and Characterization of a Non-Satellite Cell Muscle Resident Progenitor during Postnatal Development. Nature Cell Biology, 12, 257-266. [Google Scholar] [CrossRef] [PubMed]
[30] Gao, X., Usas, A., Tang, Y., Lu, A., Tan, J., Schneppendahl, J., et al. (2014) A Comparison of Bone Regeneration with Human Mesenchymal Stem Cells and Muscle-Derived Stem Cells and the Critical Role of BMP. Biomaterials, 35, 6859-6870. [Google Scholar] [CrossRef] [PubMed]
[31] Gao, X., Usas, A., Lu, A., Tang, Y., Wang, B., Chen, C., et al. (2013) BMP2 Is Superior to BMP4 for Promoting Human Muscle-Derived Stem Cell-Mediated Bone Regeneration in a Critical-Sized Calvarial Defect Model. Cell Transplantation, 22, 2393-2408. [Google Scholar] [CrossRef] [PubMed]
[32] Molligan, J., Mitchell, R., Schon, L., Achilefu, S., Zahoor, T., Cho, Y., et al. (2016) Influence of Bone and Muscle Injuries on the Osteogenic Potential of Muscle Progenitors: Contribution of Tissue Environment to Heterotopic Ossification. Stem Cells Translational Medicine, 5, 745-753. [Google Scholar] [CrossRef] [PubMed]
[33] Seegenschmiedt, M.H., Martus, P., Goldmann, A.R., et al. (1994) [Pre-and Postoperative Radiotherapy to Prevent Heterotopic Ossification of the Hip Joint]. Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesell-Schaft, 170, 281-91.
[34] Konski, A., Pellegrini, V., Poulter, C., Devanny, J., Rosier, R., McCollister Evarts, C., et al. (1990) Randomized Trial Comparing Single Dose versus Fractionated Irradiation for Prevention of Heterotopic Bone: A Preliminary Report. International Journal of Radiation Oncology Biology Physics, 18, 1139-1142. [Google Scholar] [CrossRef] [PubMed]
[35] Kan, S., Yang, B., Ning, G., Chen, L., Li, Y., Gao, S., et al. (2015) Nonsteroidal Anti-Inflammatory Drugs as Prophylaxis for Heterotopic Ossification after Total Hip Arthroplasty. Medicine, 94, e828. [Google Scholar] [CrossRef] [PubMed]
[36] Legenstein, R., Bösch, P. and Ungersböck, A. (2003) Indomethacin versus Meloxicam for Prevention of Heterotopic Ossification after Total Hip Arthroplasty. Archives of Orthopaedic and Trauma Surgery, 123, 91-94. [Google Scholar] [CrossRef] [PubMed]
[37] Forsberg, J.A. and Potter, B.K. (2010) Heterotopic Ossification in Wartime Wounds. Journal of Surgical Orthopaedic Advances, 19, 54-61.
[38] Yutani, Y., Ohashi, H., Nishimura, N., et al. (1995) Clinical Effect of Etidronate Disodium (EHDP) on Heterotopic Ossification Following Total Hip Arthroplasty. Osaka City Medical Journal, 41, 63-73.
[39] Papapoulos, S.E., Landman, J.O., Bijvoet, O.L.M., Löwik, C.W.G.M., Valkema, R., Pauwels, E.K.J., et al. (1992) The Use of Bisphosphonates in the Treatment of Osteoporosis. Bone, 13, S41-S49. [Google Scholar] [CrossRef] [PubMed]
[40] Luo, G., Sun, Z., Liu, H., Yuan, Z., Wang, W., Tu, B., et al. (2023) Verteporfin Attenuates Trauma‐induced Heterotopic Ossification of Achilles Tendon by Inhibiting Osteogenesis and Angiogenesis Involvingyap/β‐catenin Signaling. The FASEB Journal, 37, e23057. [Google Scholar] [CrossRef] [PubMed]
[41] Cohn, R.M., Schwarzkopf, R. and Jaffe, F. (2011) Heterotopic Ossification after Total Hip Arthroplasty. American Journal of Orthopedics, 40, E232-E235.
[42] Winkler, S., Wagner, F., Weber, M., Matussek, J., Craiovan, B., Heers, G., et al. (2015) Current Therapeutic Strategies of Heterotopic Ossification—A Survey Amongst Orthopaedic and Trauma Departments in Germany. BMC Musculoskeletal Disorders, 16, Article No. 313. [Google Scholar] [CrossRef] [PubMed]
[43] Pavey, G.J., Polfer, E.M., Nappo, K.E., Tintle, S.M., Forsberg, J.A. and Potter, B.K. (2015) What Risk Factors Predict Recurrence of Heterotopic Ossification after Excision in Combat-Related Amputations? Clinical Orthopaedics & Related Research, 473, 2814-2824. [Google Scholar] [CrossRef] [PubMed]
[44] Denormandie, P., de l’Escalopier, N., Gatin, L., Grelier, A. and Genêt, F. (2018) Resection of Neurogenic Heterotopic Ossification (NHO) of the Hip. Orthopaedics & Traumatology: Surgery & Research, 104, S121-S127. [Google Scholar] [CrossRef] [PubMed]
[45] Osório, T., Lemos, J., Tkachuk, O., Sousa, R. and Vasques, A. (2022) Surgical Resection Combined with Adjuvant Radiotherapy and Non-Steroidal Anti-Inflammatory Drugs in the Treatment of Heterotopic Ossification Following Total Hip Arthroplasty. Acta Médica Portuguesa, 36, 202-205. [Google Scholar] [CrossRef] [PubMed]